Physician profile
James Ryan
NPI 1699209833
$23,813.27
in general payments reported to CMS, 2019-2025
8 companies · $451 in 2025
The $451 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $22K · 2024: $1,353 · 2025: $451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $20K · Food and Beverage: $2,346 · Travel and Lodging: $1,468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $20,000.00 |
| Food and Beverage | $2,345.52 |
| Travel and Lodging | $1,467.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $21,589.61 | 2023 | |
| Stryker Corporation | $876.91 | 2024-2025 | Blueprint Patient Specific Instrumentation, Mako, Gamma |
| Seapearl East, INC | $603.63 | 2023-2025 | |
| Zimmer Biomet Holdings, INC. | $313.72 | 2023-2024 | Comprehensive Shoulder System, Identity |
| Smith+Nephew, INC. | $310.79 | 2024 | Na, Rf20000, Q-Fix |
| Ferring Pharmaceuticals INC. | $44.44 | 2025 | Euflexxa |
| Depuy Synthes Sales INC. | $38.68 | 2024-2025 | Orthovisc, Monovisc |
| Saxum Surgical, INC. | $35.49 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.